Mr. John Hennessy:

The Translarna application has concluded the assessment process through the drugs group and is listed for the December leadership meeting. I would expect the decision to be immediate after the December meeting but there are affordability issues currently being dealt with as part of the service plan preparation for 2019. There are aspects of that still outstanding. The service plan will also be concluded by then, I hope, and it should clear up matters relating to affordability.